Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss of $0.06/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. ARM
5. EXPE
6. QCOM
7. DDOG
8. CHYM
9. CPAY
10. PAYC

Go back to Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss of $0.06/Share

Sensus Healthcare Reports Record Second Quarter Financial Results

August 3, 2017 4:01 PM EDT

BOCA RATON, Fla., Aug. 3, 2017 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three and six months ended June 30, 2017.

Highlights of the second quarter of 2017 and recent weeks include (all comparisons are with the second quarter of 2016, unless otherwise noted):

Reported record revenues of $5.0 million, up 39% compared with $3.6 million Achieved gross margin of 68.7%, up from 65.0% Increased sales organization headcount to 27 including... More